Guideline / position statementindependent cross-checkfull text checked★ key study I-DRY-102 in-depth review

WCRF: dairy probably protects against bowel cancer; prostate cancer link is limited

Meat, fish and dairy products and the risk of cancer (Continuous Update Project Expert Report 2018)

Overview

World Cancer Research Fund / American Institute for Cancer Research. WCRF/AICR Diet, Nutrition, Physical Activity and Cancer: a Global Perspective (Third Expert Report) 2018

13% lower colorectal cancer risk per 400 g dairy a day; evidence for higher prostate cancer risk judged limited.

Does the study support the specific claim? Partly · Methodological quality: high

Original publication

Plain-language summary

Study explained simply
What did the researchers want to find out?

Judge whether dairy affects cancer risk.

How was the study done?

Expert review of cohort meta-analyses.

How many people, animals or samples were studied?

Many cohorts worldwide.

What was actually found?

Probable protection against colorectal cancer; limited evidence for prostate cancer increase.

How large was the observed effect?

Colorectal RR 0.87 per 400 g/day.

What do the results mean in everyday life?

Dairy is not an established cause of cancer; it probably lowers bowel cancer risk.

What are the study's limitations?

Observational data; 2018 cut-off.

What does it say about Elawady's specific claim?

Supports caution about very high intakes for prostate cancer only as a possibility; contradicts dairy as a general carcinogen.

Do the results apply to Germany and Europe?

Directly applicable.

What can explicitly not be concluded from this study?

Cannot prove that dairy causes prostate cancer.

Scientific in-depth review

1. Full reference

Authors
World Cancer Research Fund / American Institute for Cancer Research
Journal
WCRF/AICR Diet, Nutrition, Physical Activity and Cancer: a Global Perspective (Third Expert Report)
Year
2018
Identifier
Verification
verified – PDF fetched 2026-10-26 from wcrf.org (80 pages; text extracted and searched; sections on dairy read)
Retracted
no
Corrections

none known

Extent checked
full text
Conflicts of interest and funding

WCRF/AICR (charities)

2. Research question

Do meat, fish and dairy products affect cancer risk?

3. Study design and population

Study design
Guideline / position statement – Expert panel report based on CUP systematic literature reviews and dose-response meta-analyses of cohort studies
Population

Prospective cohort studies worldwide

Country

International

Period

Literature to about 2016-2017

Sample size

Colorectal: dairy 10 studies, 14,859 cases

Inclusion and exclusion criteria

CUP criteria

4. Methods and endpoints

Exposure / intervention

Dairy products, milk, cheese, calcium

Comparator

Lower intake

Endpoints

Cancer incidence by site

Statistical methods

Random-effects dose-response meta-analyses; graded judgements (convincing, probable, limited-suggestive, limited-no conclusion)

5. Actual results

Results

Strong evidence (probable): 'Consumption of dairy products probably protects against colorectal cancer'; colorectal cancer RR 0.87 (0.83-0.90) per 400 g/day dairy (I2 = 18%), RR 0.94 (0.92-0.96) per 200 g/day milk, cheese RR 0.94 (0.87-1.02) per 50 g/day. Limited-suggestive: 'The evidence suggesting that consumption of dairy products increases the risk of prostate cancer is limited' (includes total dairy, milk, cheese and yogurt); same for diets high in calcium. The Panel did not base a recommendation on dairy because evidence diverges between cancer sites.

Absolute risks

not reported

Authors' conclusion

Dairy probably protects against colorectal cancer; evidence for increased prostate cancer risk is limited-suggestive; no recommendation on dairy was made.

6. Strengths

  • Systematic, pre-specified grading
  • Dose-response meta-analyses
  • Considers cheese and yogurt within the prostate judgement

7. Weaknesses

  • Observational data
  • 2018 cut-off
  • Ovarian cancer and dairy not graded as a conclusion

8. Risk of bias

Orienting tool
none applicable
Type of assessment
simplified assessment (abstract only)
Full formal assessment
no
Overall risk of bias
low
Rationale

Expert-report grading; high methodological standard.

9. Assessment of the statistical interpretation

RR per 400 g/day is a relative dose-response estimate; the colorectal benefit is modest per unit but consistent.

10. Relevance to the specific claim

The leading cancer-prevention body rates the prostate-cancer signal as limited and the colorectal protection as probable; it applies the prostate signal to cheese and yogurt as well as milk.

11. Independent contrary findings

AHS-2 (I-DRY-108) found a stronger prostate association after 2018; MR (I-DRY-109) found no causal effect of milk on prostate cancer overall.

12. Transferability to Germany and Europe

International; applies to Europe and Egypt as biological evidence.

13. Overall methodological judgement

High-quality synthesis; calibrates the prostate claim as possible, not established.

Multidimensional assessment
Multidimensional assessment
Authenticity of the sourceverified
Methodological qualityhigh
Risk of biaslow
Precision of resultshigh
Directnessdirect
Reproducibilityreplicated
Consistency with the overall evidenceconsistent
Regional transferabilitymoderate
Adequacy of the interpretation (by the archive)not applicable

14. Open questions

Update of the prostate cancer CUP after newer cohorts and MR.

15. Linked fact checks